Study ID | Sample size, n | Age (years), mean ± SD/median (IQR) | Male, n (%) | Baseline NIHSS, mean ± SD/median (IQR) | Onset to treatment time, min, mean ± SD/median (IQR) | |||||
---|---|---|---|---|---|---|---|---|---|---|
TNK | tPA | TNK | tPA | TNK | tPA | TNK | tPA | TNK | tPA | |
Haley et al. 2010 | TNK 0.1: 31 | 31 | TNK 0.1: 67 ± 19 | 72 ± 16 | TNK 0.1: 12 (39%) | 17 (51%) | TNK 0.1: 8 (5–11) | 13 (5–17) | NA | NA |
TNK 0.25: 31 | TNK 0.25: 69 ± 15 | TNK 0.25: 16 (52%) | TNK 0.25: 10 (6–15) | |||||||
TNK 0.4: 19 | TNK 0.4: 68 ± 16 | TNK 0.4: 13 (68%) | TNK 0.4: 9 (5–17) | |||||||
Parsons et al. 2012 | TNK 0.1: 25 | 25 | TNK 0.1: 72 ± 6.9 | 70 ± 8.4 | TNK 0.1: 13 (52%) | 12 (48%) | TNK 0.1: 14.5 ± 2.3 | 14 ± 2.3 | TNK 0.1: 3.1 ± 0.9 h | 2.7 ± 0.8 h |
TNK 0.25: 25 | TNK 0.25: 68 ± 9.4 | TNK 0.25: 13 (52%) | TNK 0.25: 14.6 ± 2.3 | TNK 0.25: 3.0 ± 0.7 h | ||||||
Huang et al. 2015 | 47 | 49 | 71 ± 13 | 71 ± 12 | 30 (64%) | 31 (63%) | 12 (9–18) | 11 (8–16) | 184 ± 44 | 192 ± 45 |
Logallo et al. 2017 | 549 | 551 | 70.8 ± 14.4 | 71.2 ± 13.2 | 321 (58%) | 339 (62%) | 5.6 ± 5.4 | 5.8 ± 5.2 | 118 (79–180) | 111 (80–174) |
Campbell et al. 2018 | 101 | 101 | 70.4 ± 15.1 | 71.9 ± 13.7 | 58 (57%) | 52 (51%) | 17 (12–22) | 17 (12–22) | 125 (102–156) | 134 (104–176) |
Menon et al. 2022 | 806 | 771 | 73.33 ± 14.85 | 72.67 ± 15.6 | 424 (52.6%) | 398 (51.6%) | 10.33 ± 7.43 | 11 ± 8.14 | 135 ± 69.05 | 138 ± 69.1 |
Kvistad et al. 2022 | 100 | 104 | 73.2 ± 12.6 | 68.6 ± 15.6 | 45 (45%) | 53 (51%) | 13.4 ± 6.6 | 13.2 ± 6.4 | 103.16 ± 51.90 | 105 ± 52.62 |
Li et al. 2022 | TNK 0.1: 60 | 59 | TNK 0.1: 62.4 ± 11.1 | 66.5 ± 12.6 | TNK 0.1: 48 (80%) | 38 (64.41%) | TNK 0.1: 7.0 (5.0–10.0) | 8.0 (5.0–12.0) | TNK 0.1: 154 (56–195) | 153 (18–187) |
TNK 0.25: 57 | TNK 0.25: 64.3 ± 12.8 | TNK 0.25: 42 (73.68%) | TNK 0.25: 8.0 (5.0–12.0) | TNK 0.25: 149 (80–179) | ||||||
TNK 0.32: 60 | TNK 0.32: 64.8 ± 12.1 | TNK 0.32: 42 (70%) | TNK 0.32: 7.5 (6.0–12.0) | TNK 0.32: 147 (69–220) | ||||||
Bivard et al. 2022 | 55 | 49 | 76 (60–84) | 73 (61–80) | 33 (60%) | 30 (61%) | 8 (5–14) | 8 (5–17) | 97 (68–157) | 92 (66–31) |
Wang et al. 2023 | 710 | 707 | 67 (58–73) | 65 (58–72) | 492 (69%) | 479 (68%) | 7 (5–10) | 7 (6–10) | 180 (135–222) | 178.5 (135–230) |
Study ID | Hypertension, n (%) | Diabetes mellitus, n (%) | Hyperlipidemia, n (%) | Atrial fibrillation, n (%) | Previous stroke/TIA, n (%) | Active smoker, n (%) | Premorbid mRS ≥ 3, n (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TNK | tPA | TNK | tPA | TNK | tPA | TNK | tPA | TNK | tPA | TNK | tPA | TNK | tPA | |
Haley et al. 2010 | TNK 0.1: 25 (81%) | 22 (71%) | TNK 0.1: 6 (19%) | 4 (13%) | TNK 0.1: 16 (52%) | 17 (55%) | NA | NA | TNK 0.1: 6 (19%) | 4 (13%) | TNK 0.1: 2 (6.5%) | 7 (23%) | NA | NA |
TNK 0.25: 25 (81%) | TNK 0.25: 7 (23%) | TNK 0.25: 15 (48%) | TNK 0.25: 10 (32%) | TNK 0.25: 7 (23%) | ||||||||||
TNK 0.4: 17 (90%) | TNK 0.4: 4 (21%) | TNK 0.4: 8 (42%) | TNK 0.4: 5 (26%) | TNK 0.4: 0 (0%) | ||||||||||
Parsons et al. 2012 | TNK 0.1: 16 (64%) | 15 (60%) | TNK 0.1: 8 (32%) | 1 (4%) | TNK 0.1: 13 (52%) | 9 (36%) | TNK 0.1: 9 (36%) | 6 (24%) | NA | NA | TNK 0.1: 9 (36%) | 1 (4%) | NA | NA |
TNK 0.25: 16 (64%) | TNK 0.25: 6 (24%) | TNK 0.25: 15 (60%) | TNK 0.25: 13 (52%) | TNK 0.25: 5 (20%) | ||||||||||
Huang et al. 2015 | 20 (43%) | 28 (57%) | 7 (15%) | 7 (14%) | 4 (9%) | 7 (14%) | 19 (40%) | 15 (31%) | 12 (26%) | 11 (22%) | 13 (28%) | 10 (20%) | NA | NA |
Logallo et al. 2017 | 246 (45%) | 236 (43%) | 72 (13%) | 74 (13%) | 61 (11%) | 65 (12%) | 50 (9%) | 69 (13%) | 119 (22%) | 120 (22%) | 169 (31%) | 177 (32%) | 27 (5%) | 35 (6%) |
Campbell et al. 2018 | 64 (63%) | 63 (62%) | 10 (10%) | 18 (18%) | NA | NA | 27 (27%) | 40 (40%) | NA | NA | 18 (18%) | 11 (11%) | 7 (7%) | 12 (12%) |
Menon et al. 2022 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Kvistad et al. 2022 | 56 (56%) | 48 (46%) | 17 (17%) | 11 (11%) | 30 (30%) | 33 (32%) | 9 (9%) | 8 (8%) | NA | NA | 24 (24%) | 25 (24%) | NA | NA |
Li et al. 2022 | TNK 0.1: 43 (71.7) | 42 (71.2) | TNK 0.1: 14 (23.3) | 11 (18.6) | TNK 0.1: 17 (28.3) | 11 (18.6) | TNK 0.1: 8 (13.3) | 6 (10.2) | NA | NA | TNK 0.1: 25 (41.7) | 24 (40.7) | 0 | 0 |
TNK 0.25: 37 (64.9) | TNK 0.25: 9 (15.8) | TNK 0.25: 13 (22.8) | TNK 0.25: 4 (7.0) | TNK 0.25: 25 (43.9) | ||||||||||
TNK 0.32: 35 (58.3) | TNK 0.32: 15 (25.0) | TNK 0.32: 10 (16.7) | TNK 0.32: 14 (23.3) | TNK 0.32: 21 (35.0) | ||||||||||
Bivard et al. 2022 | 30 (55%) | 31 (63%) | 11 (30%) | 17 (35%) | 21 (38%) | 22 (45%) | 8 (15%) | 7 (15%) | 12 (21.82%) | 13 (26.53%) | 8 (15%) | 9 (18%) | 3 (5%) | 6 (12%) |
Wang et al. 2023 | 510 (72%) | 512 (72%) | 172 (24%) | 207 (29%) | 130 (18%) | 160 (23%) | 137 (19%) | 146 (21%) | NA | NA | 266 (38%) | 276 (39%) | 0 | 0 |